Hematology/Oncology News

Insurance status contributes to considerable disparities in care quality for patients with head and neck cancer, according to retrospective study results.

In 2018, at the height of the chimeric antigen receptor T-cell therapy revolution and in the heart of its implementation, Healio’s Cell Therapy Next staff went onsite to University of Pennsylvania’s newly minted center.

Genital talc powder and frequent douching were associated with an increased risk for ovarian cancer, according to a recent study.

Analyses of people with early-onset colorectal cancer showed those who lived in rural areas had greater 5-year disease-related mortality risk than those who lived in nonrural areas, according to results of a retrospective study.

Patients with chronic lymphocytic leukemia who achieved undetectable minimal residual disease achieved significantly longer PFS than patients with minimal residual disease, according to results of a systematic review and meta-analysis.

On this special edition episode, Dagny Zhu, MD, with Oncology Overdrive’s Shikha Jain, MD, and Physicianary’s Hansa Bhargava, MD, discuss leadership in medicine and the importance of mentorship with a panel of guests.

Deleting the CD5 gene from chimeric antigen receptor T cells improved their expansion, durability and tumor-killing capabilities, according to study findings.

Asian American, Native Hawaiian and Pacific Islander, or AA and NH/PI, communities continue to face significant racial disparities in health care access and outcomes across the United States, according to an expert.

Published results showed patients with a mental health diagnosis who undergo surgery for bone or soft tissue sarcoma may be at risk for longer hospital stays, readmission and surgical site infection.

A year-long pilot program of external mentorship improved confidence, advanced career development and provided networking opportunities for classical hematology trainees, according to a study published in Blood Advances.